Clinical trial
A Study in People With High Cholesterol
NCT00133380 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00133380 |
|---|---|
| Title | A Study in People With High Cholesterol |
| Official title | PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | PPAR alpha, atorvastatin, placebo |
| Enrollment | 300 |
| Start date | Jul 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Aug 23, 2005 |
| Last update posted | Apr 6, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: